Consensus Omega Healthcare Investors, Inc.

Equities

OHI

US6819361006

Real-time Estimate Cboe BZX 09:47:53 2023-12-05 am EST Intraday chart for Omega Healthcare Investors, Inc. 5-day change 1st Jan Change
31.17 USD -1.14% -1.10% +12.34%

Evolution of the average Target Price on Omega Healthcare Investors, Inc.

Price target over the last 5 years

History : Analyst Recommendations

39940ce9dc963446a0321ef5dc21d.nOiBM3_nvqlGGVDc9p70DXnuMXPBLyTPXjg6Nu1t8gw.2pHjdkrV-cUeamKmpqqhbDGodgKIYn6cNgsPboQ6g13Eq-YeLavv5CVTMw~d284d390fbafacc5ac889ad17f74aefd
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $33 From $34, Maintains Equal-Weight Rating MT
BNP Paribas Exane Downgrades Omega Healthcare Investors to Underperform From Neutral MT
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $34 From $33, Maintains Equalweight Rating MT
BNP Paribas Starts Omega Healthcare Investors at Neutral Rating, $36 Price Target MT
BofA Securities Upgrades Omega Healthcare Investors to Buy From Neutral MT
Wedbush Starts Omega Healthcare Investors at Neutral With $34 Price Target MT
Raymond James Adjusts Omega Healthcare Investors' Price Target to $36 From $33, Keeps Outperform Rating MT
RBC Initiates Omega Healthcare Investors at Sector Perform With $33 Price Target, Says Stock Price Already Reflects Recovery MT
Mizuho Securities Upgrades Omega Healthcare Investors to Buy From Neutral, Adjusts Price Target to $35 From $31 MT
Wells Fargo Adjusts Omega Healthcare Investors Price Target to $33 From $32, Maintains Equal Weight Rating MT
BMO Capital Initiates Omega Healthcare Investors With Market Perform Rating, $34.50 Price Target MT
Wells Fargo Downgrades Omega Healthcare Investors to Equalweight From Overweight, Price Target is $32 MT
Truist Securities Adjusts Omega Healthcare Investors Price Target to $33 From $29, Maintains Hold Rating MT
Mizuho Securities Adjusts Omega Healthcare Investors Price Target to $31 From $32, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $32 From $30, Maintains Overweight Rating MT
Stifel Adjusts Omega Healthcare Investors' Price Target to $33 From $36, Keeps Buy Rating MT
Wells Fargo Initiates Omega Healthcare Investors at Overweight With $30 Price Target MT
Citigroup Adjusts Price Target on Omega Healthcare Investors to $28 From $30, Maintains Neutral Rating MT
Raymond James Adjusts Price Target on Omega Healthcare Investors to $33 From $35, Maintains Outperform Rating MT
Barclays Adjusts Price Target on Omega Healthcare Investors to $31 From $33, Maintains Equalweight Rating MT
Baird Adjusts Omega Healthcare Investors' Price Target to $29 From $32, Maintains Neutral Rating MT
Scotiabank Adjusts Omega Healthcare Investors' Price Target to $30 From $32, Maintains Sector Perform Rating MT
Credit Suisse Downgrades Omega Healthcare Investors to Underperform From Neutral, Price Target is $25 MT
BofA Securities Downgrades Omega Healthcare Investors to Neutral From Buy, Adjusts Price Target to $33 From $35 MT
Raymond James Adjusts Price Target on Omega Healthcare Investors to $35 From $34, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
31.53USD
Average target price
33.27USD
Spread / Average Target
+5.51%
High Price Target
37USD
Spread / Highest target
+17.35%
Low Price Target
30USD
Spread / Lowest Target
-4.85%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Omega Healthcare Investors, Inc.

Wells Fargo Securities
BNP Paribas Exane
BofA Securities
Wedbush
Raymond James
RBC Capital Markets
Mizuho Securities
BMO Capital
Truist Securities
Stifel Nicolaus
Citigroup
Barclays
Baird
Scotiabank
Credit Suisse
Berenberg Bank
Jefferies & Co.
JMP Securities
Capital One Securities
Wolfe Research
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings
  1. Stock
  2. Equities
  3. Stock Omega Healthcare Investors, Inc. - Nyse
  4. Consensus Omega Healthcare Investors, Inc.
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer